Copper Loss Through Fistula Output
Patients with enterocutaneous fistulas lose approximately 0.1-0.2 mg of copper per day through fistula output, requiring supplementation of 0.4-0.5 mg/day of copper in parenteral nutrition to maintain copper balance.
Quantifying Copper Losses
The most direct evidence comes from a 1981 metabolic balance study that specifically measured copper losses in patients with gastrointestinal fistulas 1. This study demonstrated that:
- Patients with high-output stomas or fistulas have increased gastrointestinal copper losses compared to those with normal GI function
- Copper requirements increase from 0.3 mg/day (normal GI losses) to 0.4-0.5 mg/day in patients with diarrhea or increased fluid losses through fistulas 1
- This represents an additional 0.1-0.2 mg/day loss attributable to the fistula output itself
Clinical Context and Mechanism
The ESPEN 2022 micronutrient guideline confirms that increased gastrointestinal losses of copper are observed in patients with enterocutaneous fistulas 2. This occurs because:
- Most absorbed copper is normally lost via biliary excretion into the GI tract 2
- When fistula output bypasses normal reabsorption mechanisms, this copper is lost externally
- The magnitude of loss correlates with the volume and location of fistula output
Practical Supplementation Strategy
For patients on parenteral nutrition with enterocutaneous fistulas:
- Standard PN copper provision of 0.5-1.2 mg/day may be insufficient 2
- Target 0.4-0.5 mg/day minimum based on metabolic balance data 1
- Monitor serum copper levels: Values <12 μmol/L with CRP >20 mg/L suggest deficiency; values <8 μmol/L indicate need for repletion 2
- Treatment of established deficiency requires 4-8 mg/day 2
Important Caveats
- Plasma copper does not reliably reflect copper balance and cannot be used as the sole guide for supplementation 1
- Urinary copper excretion is approximately twice normal in patients receiving PN 1
- Copper infused in excess of requirements is retained, not excreted 1, so avoid over-supplementation in patients with cholestasis
- Patients with abnormal liver excretory function have decreased GI copper losses and may require less supplementation 1
Monitoring Approach
- Check serum copper at baseline and every 6-12 months during long-term PN 2
- More frequent monitoring if cholestasis develops 2
- Watch for clinical signs of deficiency: microcytic anemia, neutropenia, delayed wound healing, hair depigmentation 2
- Adjust supplementation based on fistula output volume and liver function